BIT 4.35% 2.2¢ biotron limited

Ann: $1.64M R&D rebate received, page-67

  1. 10,305 Posts.
    lightbulb Created with Sketch. 2808
    This "coming weeks" BS is wearing a bit thin now, agree 100%, but I'm still super confident that the wait will be worth it.
    The SP spiked 26x back in 2018 when the successful HIV trials was announced; I know we have the antiretrovirals to help keep HIV at bay but the need for something to drain the reservoirs of this insidious virus is just as great now as it was back then - it would be a BIG deal!

    Let's factor in a world first small molecule anitviral treatment that doesn't have the side effects or contraindications that the current offerings such as Paxlovid, Remdesivir and Molnupiravir have and you can see why some of us punters on here are willing to hang around here despite the shoddy timeline guidance provided by management.

    Onwards and upwards BIT!
    Last edited by Glitterati: 10/02/24
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
2.2¢
Change
-0.001(4.35%)
Mkt cap ! $19.85M
Open High Low Value Volume
2.2¢ 2.3¢ 2.1¢ $5.848K 265.8K

Buyers (Bids)

No. Vol. Price($)
1 1098181 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 97130 1
View Market Depth
Last trade - 15.32pm 17/09/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.